Sumitomo Mitsui Trust Holdings, Inc. Biogen Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 416,960 shares of BIIB stock, worth $56.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
416,960
Previous 391,496
6.5%
Holding current value
$56.5 Million
Previous $59.9 Million
4.7%
% of portfolio
0.04%
Previous 0.04%
Shares
32 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.31 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.16 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.97 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$633 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $19.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...